期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CHA2DS2-VASc评分与非瓣膜性心房颤动缺血性脑卒中患者的预后关系 被引量：2

原文传递
导出
摘要 目的探讨CHA2DS2-VASc评分与非瓣膜性心房颤动（NVAF）缺血性脑卒中患者预后的关系。方法对96例NVAF缺血性脑卒中患者进行分析并完成CHA2DS2-VASc评分、入院、出院NIHSS评分及3个月后改良Rankin量表（mRS）评分。结果住院期间病情改善与未改善的患者CHA2DS2-VASc评分比较差异有统计学意义（P〈0．05），3个月后预后良好与预后不良的患者CHA2DS2-VASc评分比较差异有统计学意义（P〈0．05），不同CHA2DS2-VASc评分组患者住院期间病情改善及3个月后预后情况比较差异有统计学意义（P〈0．05）。结论CHA2DS2-VASc评分可帮助评估患者早期病情改善及预后情况。
作者 闫俊杰 高鹏飞
机构地区 河南省许昌市中心医院急诊科 河南省许昌市中心医院神经内科
出处 《中国实用医刊》 2015年第11期122-123,共2页 Chinese Journal of Practical Medicine
关键词 非瓣膜性房颤 缺血性脑卒中 CHA2DS2-VASc评分 预后
分类号 R743.34 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献6

  • 1Lip GY, Nieuwlaat R, Pisters R, et al. Refining chnical risk stratifi- cation for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on at- ria! fibrillation[J]. Chest, 2010, 137(5): 263-272.
  • 2Valentin F, Lars E, Rydrn, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology/American Heart Asso- ciation Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) [J]. Eur Heart J, 2006, 27(8) : 979-2030.
  • 3Nakajima T, Nishimura H,Tachibana H, et al. Factors Associated with Functional Outcomes of Patients with Cerebral Embolism Due to Nonva- lvular Atrial Fibrillation [J]. Imem Med, 2011,50(10) : 197-204.
  • 4Jorgensen H, Reith J, Nakayama H, et al. What determines good re- covery in patients with the most severe strokes [ J ] ? The Copenhagen Stroke Study, Stroke, 1999, 30( 11 ) : 2008-2012.
  • 5Honga HI, Kim YD, Cha MJ, et al. Early neurological outcomes ac- cording to CHADS2 score in stroke patients with non-valvular atrial fi- brillation[ J]. Eur J Neurol,2012, 19(2) : 284-290.
  • 6高朋飞,秦琴保.CHA_2DS_2-VASc评分在非瓣膜性房颤缺血性脑卒中患者中的应用[J].中国神经精神疾病杂志,2014,40(1):21-25. 被引量：6

二级参考文献14

  • 1穆利英,杜凤和,徐秀英.非瓣膜性心房颤动患者脑卒中危险因素的临床分析[J].首都医科大学学报,2006,27(3):375-378. 被引量：2
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量：33041
  • 3Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atri- al fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation[J]. Chest, 2010, 137(2): 263-272.
  • 4Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the manage- ment of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2010, 31(19): 2369-2429.
  • 5Samuels OB, Joseph GJ, Lynn M J, et al. A standardized method for measuring intracranial arterial stenosis[J]. Am J Neuroradiol, 2000, 21(4): 643-646.
  • 6Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspi- rin Symptomatic intracranial disease study[J]. Neurology, 1995,45(8): 1488-1493.
  • 7Gao S, Wang YJ, Xu AD, et al. Chinese ischemic stroke subclas- sification[J]. Front Neurol, 2011, 2(6): 1-5.
  • 8Kim YD, Cha M J, Kim J, et al. Increases in cerebral atheroscle- rosis according to CHADS2 scores in patients with stroke with nonvalvular atrial fibrillation[J]. Stroke, 2011, 42(4):930-934.
  • 9Takahashi W, Ohnuki T, Ide M, et al. Stroke risk of asymptomat- ic intra- and extracranial large-artery disease in apparently healthy adults[J]. Cerebrovasc Dis, 2006, 22(4):263-270.
  • 10Cha MJ, Kim YD, Nam HS, et al. Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2DS2-VASc scores[J]. Eur J Neurol, 2012, 19(3): 473-479.

共引文献5

同被引文献28

  • 1王广晖.缺血性脑卒中复发因素分析[J].中国医药导报,2005,2(17). 被引量：2
  • 2Shah AJ,Liu X.,Hadidi AS,et al.Early management of atrial fibrillation:from imaging to drugs to ablation[J].Nat Rev Cardiol,2010,7(6):345-354.
  • 3Magnani JW,Rienstra M,Lin H,et al.Atrial fibrillation:current knowledge and future directions in epidemiology and genomics[J].Circulation,2011,124(18):1982-1993.
  • 4Gattellari M,Goumas C,Aitken R,et al.Outcomes for patients with ischaemic stroke and atrial fibrillation:the PRISM study[J].Cerebrovasc Dis,2011,32(4):370-382.
  • 5Camm AJ,Lip GY,De Caterina R,et al,2012 focused update of the ESC Guidelines for the management of atrial fibrillation:an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association[J].Europace,2012,14(10):1385-1413.
  • 6Turpie AG.Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation[J].Ther Clin Risk Manag,2014,10:197-205.
  • 7Colilla S,Crow A,Simon T,et al.Projected estimates of prevalence and annual growth rate of atrial fibrillation in the United States from a dynamic age-period progression model[J].Circ Cardiovasc Qual 0utcomes,2012,5:A2056.
  • 8Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006 guide-lines for the management of patients with atrial fibrillation:full text:a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee fox practice guide-lines(writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation)developed in collaboration with the European heart rhythm association and the heart rhythm society[J].Europace,2006,8(9):651-745.
  • 9Pieri A,Lopes TO,Gabhai AA,Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation[J].Int J Stroke,2011,6(5):466.
  • 10Boriani G,Botto GL,Padeletti L,et al.Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring[J].Stroke,2011,42(6):1768-1770.

引证文献2

二级引证文献9

中国实用医刊
2015年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部